Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2010
Operating Activities
Net Income $17.5M
Depreciation & Amortization $4.4M
Depreciation $2.7M
Amortization $1.7M
Stock-Based Compensation $2.2M
Net Cash from Operating Activities $28.0M
Investing Activities
Capital Expenditures $5.4M
Business Acquisitions $20.3M
Net Cash from Investing Activities $-25.7M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $6.7M
Net Change in Cash $9.0M
Free Cash Flow $22.6M
← Newer Page 3 of 3 Older →